Reliability of antibody tests for COVID-19 diagnosis

被引:0
|
作者
Coplu, Nilay [1 ]
Kilinc, Cetin [2 ]
Gozalan, Aysegul [3 ]
Calisir, Busra [2 ]
Sonmez, Cemile [4 ,5 ]
Gul, Mustafa Muhammet [6 ]
Aygun Ahlatcioglu, Zeynep
机构
[1] Ankara City Hosp, Med Microbiol, Ankara, Turkiye
[2] Kastamonu Training & Res Hosp, Med Microbiol, Kastamonu, Turkiye
[3] Alanya Alaaddin Keykubat Univ, Med Microbiol, Antalya, Turkiye
[4] Minist Hlth, Microbiol Reference Labs, Ankara, Turkiye
[5] Minist Hlth, Biol Prod Dept, Sexually Transmitted Dis Reference Lab, Publ Hlth Gen Directorate, Ankara, Turkiye
[6] Kastamonu Training & Res Horpital, Infect Dis Clin, Kastamonu, Turkiye
来源
MARMARA MEDICAL JOURNAL | 2023年 / 36卷 / 01期
关键词
COVID-19; Antibody; Validity; Chemiluminescent; Electrochemiluminescence; ELISA; PERFORMANCE;
D O I
10.5472/marumj.1245068
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The reverse transcription-polymerase chain reaction test (RT-PCR) is the gold standard for the diagnosis of coronavirus disease 2019 (COVID-19), and antibody tests are useful as supplemental tools for diagnosis, for measuring the population's immunity levels, and for checking infection in asymptomatic contacts. This study aimed to evaluate the reliability of five commercial antibody detection test kits. Materials and Methods: The reliability of the Colloidal Gold COVID-19 IgG/IgM Rapid Test Kit, Antibody Rapid Test Hotgen, Beijing Hotgen Biotech Co., Ltd., China), Abbott Chemiluminescent Microparticle Immunoassay (Illinois, USA), Roche Electrochemiluminescence Immunoassay (Roche Diagnostics, Switzerland), Siemens Chemiluminescence (Munich, Germany), and Euroimmun ELISA (Lubeck, Germany) for COVID-19 diagnosis was studied. The antibody-negative group included 50 sera from 2018, and the antibody-positive group included 98 patients with positive RT-PCR results from whom blood samples had been collected 3-9 weeks after hospital discharge. Statistical analysis was performed using SPSS version 23.0 (IBM Corporation, Armonk, NY, USA). The antibody tests' validity and intra-assay reproducibility were examined, and the Cohen's kappa coefficients were obtained. The disease prevalence was pegged at 10%. Results: The antibody tests' sensitivity (69.12-72.46%) and positive predictive values (42.44-100.0%) were low, and their specificity (89.58-100%) and negative predictive values (96.31-97.03%) were high. Their accuracy rates varied from 87.54% to 97.25%, and their intra-assay coefficients of variation varied from 1% to 10%. Conclusion: The agreement between the results of the antibody detection test kits was higher when the kits were classified according to the targeted antigens. The time of blood sample collection, targeted antigens, and antibody types affected the results. Serological tests were found to be useful, and the commercial kits were found to be largely reliable, although, some parameters need to be improved.
引用
收藏
页码:93 / 98
页数:6
相关论文
共 50 条
  • [41] Infection and infectivity: Utility of rapid antigen tests for the diagnosis of COVID-19
    Barreiro, Pablo
    San-Roman, Jesus
    del Mar Carretero, Maria
    Javier Candel, Francisco
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2021, 34 : 46 - 48
  • [42] COVID-19 diagnosis by routine blood tests using machine learning
    Matjaž Kukar
    Gregor Gunčar
    Tomaž Vovko
    Simon Podnar
    Peter Černelč
    Miran Brvar
    Mateja Zalaznik
    Mateja Notar
    Sašo Moškon
    Marko Notar
    Scientific Reports, 11
  • [43] COVID-19 diagnosis by routine blood tests using machine learning
    Kukar, Matjaz
    Guncar, Gregor
    Vovko, Tomaz
    Podnar, Simon
    Cernelc, Peter
    Brvar, Miran
    Zalaznik, Mateja
    Notar, Mateja
    Moskon, Saso
    Notar, Marko
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [44] The different tests for the diagnosis of COVID-19 - A review in Brazil so far
    Santarine Laureano, Ana Flavia
    Riboldi, Marcia
    JORNAL BRASILEIRO DE REPRODUCAO ASSISTIDA, 2020, 24 (03): : 340 - 346
  • [45] Covid-19: Government faces legal action over contract for antibody tests
    Dyer, Clare
    BMJ-BRITISH MEDICAL JOURNAL, 2021, 373 : n965
  • [46] COVID-19 Antibody Tests Perform Well in Head-to-Head Comparison
    Abbasi, Jennifer
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 324 (18): : 1818 - 1818
  • [47] COVID-19 Vaccines and Public Anxiety: Antibody Tests May Be Widely Accepted
    Liu, Leyuan
    Wang, Xiaoxiao
    Li, Xiaoguang
    Li, Nan
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [48] Assessment of humoral responses in COVID-19 using various quantitative antibody tests
    Wakui, Masatoshi
    Uwamino, Yoshifumi
    Kurafuji, Toshinobu
    Noguchi, Masayo
    Ohno, Akemi
    Yokota, Hiromitsu
    Kikuchi, Haruhito
    Hasegawa, Naoki
    Saya, Hideyuki
    Murata, Mitsuru
    ANNALS OF CLINICAL BIOCHEMISTRY, 2021, 58 (04) : 368 - 376
  • [49] Why covid-19 antibody tests are not the game changer the UK government claims
    Armstrong, Stephen
    BMJ-BRITISH MEDICAL JOURNAL, 2020, 369
  • [50] Evaluation of the usability of various rapid antibody tests in the diagnostic application for COVID-19
    Uwamino, Yoshifumi
    Wakui, Masatoshi
    Aoki, Wataru
    Kurafuji, Toshinobu
    Yanagita, Emmy
    Morita, Maasa
    Nagata, Mika
    Inose, Rika
    Noguchi, Masayo
    Yokota, Hiromitsu
    Hasegawa, Naoki
    Saya, Hideyuki
    Murata, Mitsuru
    ANNALS OF CLINICAL BIOCHEMISTRY, 2021, 58 (03) : 174 - 180